Status:
NOT_YET_RECRUITING
Bronchoalveolar Lavage in Interstitial Lung Diseases to Characterization of Specific Inflammatory Cellular Infiltrate in Different Interstitial Lung Diseases
Lead Sponsor:
Maha Ahmed Abd EL Gawad Mohammed Okasha
Conditions:
Interstitial Lung Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Interstitial lung disease (ILD) represents a various group of disorders characterized by inflammation and fibrosis within the lung parenchyma.\[1\] ILD refers to a group of diffuse parenchymal lung di...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Clinical suspicion of ILD based on symptoms, clinical examination, and radiological findings or newly diagnosed cases .
- HRCT findings consistent with ILD
- Willingness to undergo bronchoscopy with BAL and provide informed consent
Exclusion
- Hemodynamic instability or ICU admission at time of evaluation
- Oxygen saturation \< 88% on room air or \< 92% on oxygen therapy
- Absolute contraindications to bronchoscopy (e.g., uncorrected bleeding diathesis, recent myocardial infarction)
- Associated chronic chest diseases other than ILD (COPD. bronchial asthma and lung cancer )
- Known active pulmonary infection or recent antibiotic treatment (\< 2 weeks)
- Pregnancy
Key Trial Info
Start Date :
December 4 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 4 2027
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT07208201
Start Date
December 4 2025
End Date
December 4 2027
Last Update
October 6 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.